Polymorphisms of tumor-related genes IL-10, PSCA, MTRR and NOC3L are associated with the risk of gastric cancer in the Chinese Han population

Abstract

BackgroundGastric cancer is the fourth most common cancer in the world. Environmental and genetic factors both play critical roles in the etiology of gastric cancer. Hundreds of SNPs have been identified to have association with the risk of gastric cancer in many races. In this study, 25 SNPs in genes for IL-10, IL-1B, MTRR, TNF-а, PSCA, PLCE1 and NOC3L were analyzed to further evaluate their associations with gastric cancer susceptibility in the Chinese Han population. MethodsTwo hundred and seventy nine gastric cancer patients and 296 healthy controls were recruited in this study. SNP genotyping was conducted using Sequenom MassARRAY RS1000. Data management and statistical analyses were conducted by Sequenom Typer 4.0 Software and Pearson's χ2 test. ResultsOne protective allele and three risk alleles for gastric cancer patients were found in this study. The allele “G” of rs1801394 in MTRR showed an association with a decreased risk of gastric cancer: odds ratio (OR)=0.74, 95% confidence interval (95% CI)=0.57–0.97, P=0.030 in the additive model; OR=0.495, 95% CI=0.26–0.95, P=0.034 in the recessive model. The other three SNPs, the allele “C” of rs1800871 in IL10 (OR=1.33, 95% CI=1.04–1.90; P=0.026 in the additive model; OR=1.46, 95% CI=1.04–2.06; P=0.030 in the recessive model), the allele “A” of rs2976391 in PSCA (OR=1.30, 95% CI=1.01–1.66; P=0.041 in the additive model and OR=1.48, 95% CI=1.04–2.11, P=0.028 in the recessive model), and the allele “G” of rs17109928 in NOC3L gene (OR=1.34, 95% CI=1.01–1.78; P=0.042 by additive model analysis; OR=1.47, 95% CI=1.04–2.07, P=0.028 by dominant model analysis), showed an association with an increased risk of gastric cancer. ConclusionsThese results indicate the importance of four gastric cancer susceptibility polymorphisms of IL-10, NOC3L, PSCA and MTRR in the Chinese Han population, which could be used in the determination of gastric cancer risk in clinical practice.